Early research (Phase 1)Ended earlyNCT01183468
What this trial is testing
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 17